Replies to post #27620 on Relief Therapeutics Holding AG (RLFTF)

[Tiger Money]

How is the science of RLF-100? Is it effective? Does the drug target the lungs where Covid latches onto the cells that regulate O2 blood flow? Is it safe? Is it easy to produce? Why have NeuroRX and Relief announced their profit spilt up publicly? Why have they announced partners to work with to create and distribute this drug? Why did dr. Javitt make a big deal in one of the videos about hitting 102 patients? Why is GEM continuing to invest a lot more? Why was RLFTF allowed to be put on the FDA fast track?

COME ON PEOPLE! I could keep asking rhetorical questions that u all obviously know the answers to! Hence rhetorical. Perhaps the 102 people question is fuzzy to some but go back and watch the video! It was the FDA telling them that is the minimum in the 144 person study. Watch it again! Dr J talks to the fda daily! Hhhmmmm

KNOW what u own! Seriously people!

[Pcilliterate]

Relax. We are good.





"A randomized placebo-controlled trial of Aviptadil is underway that has enrolled more than 130 patients. In that trial, no drug-related serious adverse effects were seen and an independent data safety board determined that the trial should continue with a clear possibility that a difference between RLF-100 and placebo will be seen."

https://clinicaltrials.gov/ProvidedDocs/39/NCT04453839/ICF_002.pdf